Red cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients

Abstract Whether red cell distribution width (RDW) can be a potential indicator for diabetic nephropathy (DN) is unknown. A total of 809 type 2 diabetes mellitus (T2D) patients were divided into 4 groups according to the quartiles (Q) of the RDW (%): Q1 ≤ 12.4 (n = 229), 12.4 < Q2 ≤ 12.9 (n = 202...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiao-fen Xiong, Yuan Yang, Xianghui Chen, Xuejing Zhu, Chun Hu, Yachun Han, Li Zhao, Fuyou Liu, Lin Sun
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/297cf738427946ab8ee90406db93ff18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:297cf738427946ab8ee90406db93ff18
record_format dspace
spelling oai:doaj.org-article:297cf738427946ab8ee90406db93ff182021-12-02T12:31:55ZRed cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients10.1038/s41598-017-02904-92045-2322https://doaj.org/article/297cf738427946ab8ee90406db93ff182017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-02904-9https://doaj.org/toc/2045-2322Abstract Whether red cell distribution width (RDW) can be a potential indicator for diabetic nephropathy (DN) is unknown. A total of 809 type 2 diabetes mellitus (T2D) patients were divided into 4 groups according to the quartiles (Q) of the RDW (%): Q1 ≤ 12.4 (n = 229), 12.4 < Q2 ≤ 12.9 (n = 202), 12.9 < Q3 < 13.5 (n = 168), Q4 ≥ 13.5 (n = 210). Results showed that the levels in Q4 group was higher in age, disease duration, systolic blood pressure, blood urea nitrogen, creatinine, uric acid and proteinuria but lower in hemoglobin, serum albumin and glycosylated hemoglobin compared to Q1 group. Furthermore, the incidences of DN, diabetic peripheral neuropathy, hypertension and coronary heart disease in the Q3 or Q4 group were higher compared to Q1 group. Medications including calcium channel blockers and antiplatelet therapy also showed higher frequencies in Q3 or Q4 group compared to Q1. Logistic regression indicated that the antiplatelet therapy (OR = 2.065), hypertension (OR = 2.819), creatinine (OR = 4.473) and proteinuria (OR = 2.085) were positively associated with level of Q4 group, but higher hemoglobin (OR = 0.021) and serum Ca2+ (OR = 0.178) were negatively associated with Q4. This data suggest that high level of RDW in T2D patients indicates a higher risk and a poor prognosis for DN.Xiao-fen XiongYuan YangXianghui ChenXuejing ZhuChun HuYachun HanLi ZhaoFuyou LiuLin SunNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Xiao-fen Xiong
Yuan Yang
Xianghui Chen
Xuejing Zhu
Chun Hu
Yachun Han
Li Zhao
Fuyou Liu
Lin Sun
Red cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients
description Abstract Whether red cell distribution width (RDW) can be a potential indicator for diabetic nephropathy (DN) is unknown. A total of 809 type 2 diabetes mellitus (T2D) patients were divided into 4 groups according to the quartiles (Q) of the RDW (%): Q1 ≤ 12.4 (n = 229), 12.4 < Q2 ≤ 12.9 (n = 202), 12.9 < Q3 < 13.5 (n = 168), Q4 ≥ 13.5 (n = 210). Results showed that the levels in Q4 group was higher in age, disease duration, systolic blood pressure, blood urea nitrogen, creatinine, uric acid and proteinuria but lower in hemoglobin, serum albumin and glycosylated hemoglobin compared to Q1 group. Furthermore, the incidences of DN, diabetic peripheral neuropathy, hypertension and coronary heart disease in the Q3 or Q4 group were higher compared to Q1 group. Medications including calcium channel blockers and antiplatelet therapy also showed higher frequencies in Q3 or Q4 group compared to Q1. Logistic regression indicated that the antiplatelet therapy (OR = 2.065), hypertension (OR = 2.819), creatinine (OR = 4.473) and proteinuria (OR = 2.085) were positively associated with level of Q4 group, but higher hemoglobin (OR = 0.021) and serum Ca2+ (OR = 0.178) were negatively associated with Q4. This data suggest that high level of RDW in T2D patients indicates a higher risk and a poor prognosis for DN.
format article
author Xiao-fen Xiong
Yuan Yang
Xianghui Chen
Xuejing Zhu
Chun Hu
Yachun Han
Li Zhao
Fuyou Liu
Lin Sun
author_facet Xiao-fen Xiong
Yuan Yang
Xianghui Chen
Xuejing Zhu
Chun Hu
Yachun Han
Li Zhao
Fuyou Liu
Lin Sun
author_sort Xiao-fen Xiong
title Red cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients
title_short Red cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients
title_full Red cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients
title_fullStr Red cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients
title_full_unstemmed Red cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients
title_sort red cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/297cf738427946ab8ee90406db93ff18
work_keys_str_mv AT xiaofenxiong redcelldistributionwidthasasignificantindicatorofmedicationandprognosisintype2diabeticpatients
AT yuanyang redcelldistributionwidthasasignificantindicatorofmedicationandprognosisintype2diabeticpatients
AT xianghuichen redcelldistributionwidthasasignificantindicatorofmedicationandprognosisintype2diabeticpatients
AT xuejingzhu redcelldistributionwidthasasignificantindicatorofmedicationandprognosisintype2diabeticpatients
AT chunhu redcelldistributionwidthasasignificantindicatorofmedicationandprognosisintype2diabeticpatients
AT yachunhan redcelldistributionwidthasasignificantindicatorofmedicationandprognosisintype2diabeticpatients
AT lizhao redcelldistributionwidthasasignificantindicatorofmedicationandprognosisintype2diabeticpatients
AT fuyouliu redcelldistributionwidthasasignificantindicatorofmedicationandprognosisintype2diabeticpatients
AT linsun redcelldistributionwidthasasignificantindicatorofmedicationandprognosisintype2diabeticpatients
_version_ 1718394206653775872